Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Regorafenib in Patients With Advanced Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MCLA-117 in Acute Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
- Status
- UNKNOWN
- Phase
- PHASE4
Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
- Status
- UNKNOWN
- Phase
- N/A
Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia
- Status
- COMPLETED
- Phase
- PHASE2
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
- Status
- COMPLETED
- Phase
- PHASE2
Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE3
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1